Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

MediWound (NASDAQ:MDWD) reported a wider first-quarter loss and lower revenue compared with the prior-year period, while management reaffirmed its 2026 revenue outlook and said it continued to advance its EscharEx and NexoBrid programs. On the company’s earnings call, Chief Executive Officer Ofer G

MarketBeat

Kingsoft Cloud Q1 Earnings Call Highlights

Kingsoft Cloud (NASDAQ:KC) reported stronger first-quarter 2026 revenue as demand for artificial intelligence-related cloud services accelerated, with management saying AI cloud became the majority contributor to the company’s public cloud services revenue for the first time. Chairman and CEO Tao Z

MarketBeat

Heidmar Maritime Q1 Earnings Call Highlights

Heidmar Maritime (NASDAQ:HMR) reported a sharp first-quarter turnaround as higher tanker rates, fleet additions and lower general and administrative expenses boosted earnings, Chief Executive Officer Pankaj Khanna said on the company’s earnings call. For the three months ended March 31, 2026, Heidm

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Micron’s $1 Trillion Memory Melt-Up

The unprecedented structural supply deficit in memory chips has handed suppliers absolute pricing power, driving massive free cash flow growth.

MarketBeat

Quantum Computing's Commercial Breakout Has Arrived

The quantum computing industry is transitioning from theoretical research into utility-scale commercial infrastructure with robust enterprise service adoption.

MarketBeat

Bank of Nova Scotia Q2 Earnings Call Highlights

Bank of Nova Scotia (NYSE:BNS) reported stronger second-quarter fiscal 2026 results, with management pointing to revenue growth, expense discipline and rising returns across several business lines while also acknowledging a more uncertain credit backdrop. President and Chief Executive Officer Scott

MarketBeat

PDD Q1 Earnings Call Highlights

PDD (NASDAQ:PDD) Holdings reported first-quarter 2026 revenue of RMB 106.2 billion, up 11% from a year earlier, as management emphasized a multiyear push to deepen supply chain investments and expand a new first-party brand business. On the company’s earnings call, Co-Chairman and Co-Chief Executiv

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

HICL Infrastructure H2 Earnings Call Highlights

HICL Infrastructure (LON:HICL) said its annual results were supported by strong operational performance, accretive asset sales and improved cash generation, as the infrastructure investment company outlined a higher dividend target and continued focus on disciplined capital allocation. During the a

MarketBeat

Modine’s $4B AI Coup Freezes Out the Competition

Modine is rapidly transforming the thermal management industry by securing massive hyperscaler agreements to support global artificial intelligence.

MarketBeat

What Investors Need to Know About TSMC's Hefty 17% Dividend Increase

See what TSMC's dividend yield looks like after its latest increase, and the wrinkles in this company's dividend profile investors cannot overlook.

MarketBeat

The SpaceX IPO Frenzy Is Creating 2 Very Different Bets

Institutional capital is strategically rotating into mid-cap space logistics equities ahead of the highly anticipated initial public offering of SpaceX.

MarketBeat

AI Can’t Reach the Real World Without These 3 Stocks

5G is absolutely essential for AI to function outside of the datacenters. 5G is the nervous system connecting AI to the IoT effectively.

MarketBeat

Mirum Pharmaceuticals Enters Catalyst-Rich Stretch as LIVMARLI Sales and Pipeline Advance

Mirum Pharmaceuticals (NASDAQ:MIRM) executives said the rare disease company is entering a catalyst-heavy period, with recent positive clinical updates, ongoing commercial momentum for LIVMARLI and additional business development activity expanding its portfolio. Speaking at RBC Capital Markets’ 20

MarketBeat

MacroGenics Eyes $200M Cash Boost, 2028 Runway Ahead of Cancer Pipeline Updates

MacroGenics (NASDAQ:MGNX) Chief Executive Officer Eric Risser said the biotechnology company has strengthened its balance sheet through two recent transactions while preparing for a series of clinical updates across its oncology pipeline. Speaking during an informal discussion hosted by Stifel seni

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Hafnia Q1 Earnings Call Highlights

Hafnia (NYSE:HAFN) reported a sharply higher first-quarter 2026 profit as management said geopolitical disruption and tighter tanker availability drove freight rates higher across the product tanker market. Chief Executive Officer Mikael Skov said the quarter was “transformative” for the tanker ind

MarketBeat

Aroundtown Q1 Earnings Call Highlights

Aroundtown (ETR:AT1) reported higher first-quarter rental income and lifted its 2026 absolute FFO guidance after increasing its stake in Grand City Properties, while management said the company remains focused on capital recycling, conversions and balance-sheet flexibility amid a volatile macroecono

MarketBeat

Microchip Technology Sees Demand Rebound, Margin Gains as Bookings Hit 4-Year High

Microchip Technology (NASDAQ:MCHP) is seeing a broad-based recovery in demand and expects continued margin improvement as it ramps production and works down remaining underutilization costs, Chief Financial Officer Eric Bjornholt said at JPMorgan’s 54th Annual Technology and Media Communications Con

MarketBeat

Greencore Group H1 Earnings Call Highlights

Greencore Group (LON:GNC) said its enlarged U.K. convenience foods business delivered higher first-half revenue and profit following the acquisition of Bakkavor UK, while management said integration work is progressing without disruption to service levels or customer relationships. Presenting the c

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Lyell Immunopharma Targets 2027 FDA Filing as CAR-T Pipeline Advances

Lyell Immunopharma (NASDAQ:LYEL) President and CEO Lynn Seely outlined the company’s clinical development priorities, regulatory strategy and manufacturing plans during a Stifel investor session moderated by Stephen Willey, senior biotech analyst at Stifel. Seely described Lyell as a cell therapy c

MarketBeat

Pets at Home Group H2 Earnings Call Highlights

Pets at Home Group (LON:PETS) executives said the company is seeing early signs of momentum from its retail turnaround plan, while cautioning that the veterinary business is likely to see more subdued revenue growth in the near term before improving as the pandemic-era pet cohort ages. Speaking on

MarketBeat

Logitech International CEO Eyes AI, B2B Growth as Next Investment Push Begins

Logitech International (NASDAQ:LOGI) Chief Executive Hanneke Faber said the company is entering its next phase from a position of financial strength, with plans to increase investment in innovation, business-to-business sales and marketing while keeping margins near the high end of its long-term mod

MarketBeat

Qfin Q1 Earnings Call Highlights

Qfin (NASDAQ:QFIN) reported lower first-quarter 2026 revenue and profit as management described continued pressure across China’s consumer credit market, but said recent risk-control measures are beginning to show results. CEO Haisheng Wu said China’s consumer credit industry has been undergoing “p

MarketBeat

Agora Q1 Earnings Call Highlights

Agora (NASDAQ:API) reported first-quarter 2026 revenue above its guidance range and posted its sixth consecutive quarter of GAAP profitability, as management pointed to continued growth in real-time engagement services and rising demand for conversational AI products. Founder, Chairman and CEO Tony

MarketBeat

BOX Q1 Earnings Call Highlights

BOX (NYSE:BOX) reported a stronger-than-expected start to fiscal 2027, with management pointing to growing adoption of its Enterprise Advanced offering and AI-driven content workflow products as key drivers of its results. On the company’s first-quarter earnings call, Box Co-founder and CFO Dylan S

MarketBeat

IDEAYA Biosciences Spotlights Darovasertib Win, FDA Review Path at Oncology Summit

IDEAYA Biosciences (NASDAQ:IDYA) executives highlighted recent clinical progress across the company’s oncology pipeline during a fireside chat at TD Cowen’s seventh annual Oncology Innovation Summit, with the discussion focused primarily on darovasertib combinations in uveal melanoma and several ear

1 … 21 22 23 24

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.